Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2012
09/20/2012WO2012125623A2 Cleavage inhibitors of transforming growth factor beta type i receptor and uses thereof in cancer therapy
09/20/2012WO2012125569A2 Anti-cd40 antibodies and uses thereof
09/20/2012WO2012125551A1 Listeria-based adjuvants
09/20/2012WO2012125525A2 Equine rhinitis vaccine
09/20/2012WO2012125510A1 Combination therapies for hematologic malignancies
09/20/2012WO2012125124A1 Fgfr1 antibodies and treatment of cancer
09/20/2012WO2012124631A1 Adjuvant composition containing citrulline
09/20/2012WO2012124334A1 Antibody, pharmaceutical composition used for treatment of breast cancer, tumor test method, and reagent for testing tumor
09/20/2012WO2012123926A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates
09/20/2012WO2012123759A1 Treatment for peanut allergy
09/20/2012WO2012123755A1 Re-directed immunotherapy
09/20/2012WO2012123504A1 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence
09/20/2012WO2012123269A1 Immunogenic compositions and methods for their use
09/20/2012WO2012122858A1 Method for producing virus-like particle by using drosophila cell and applications thereof
09/20/2012WO2012122725A1 Vaccine injection, preparation method and use thereof
09/20/2012WO2012122640A1 Compositions, diagnostic methods using epithelial extracellular matrix proteins
09/20/2012WO2012122629A1 A method of vaccination comprising a histone deacetylase inhibitor
09/20/2012WO2012122618A1 Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response
09/20/2012WO2012122590A1 Antibody recognizing n-domain of midkine
09/20/2012WO2012106231A3 Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza a viruses
09/20/2012WO2012103510A8 Advanced prime and boost vacinne
09/20/2012WO2012103464A3 Oral thin film vaccine preparation
09/20/2012WO2012088247A3 Anti-c5/c5a/c5adesr antibodies and fragments
09/20/2012WO2012076985A8 Granzyme b inhibitor compositions, methods and uses for promoting wound healing
09/20/2012US20120240245 Methods and compositions for detecting and treating retinal diseases
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120237972 Mammalian-type glycosylation in plants
09/20/2012US20120237605 Multifunctional Metal Nanoparticles Having A Polydopamine-Based Surface and Methods of Making and Using the Same
09/20/2012US20120237569 Emulsified composition for dilution and cancer vaccine composition
09/20/2012US20120237549 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
09/20/2012US20120237547 Live attenuated rotavirus vaccine for oral administration
09/20/2012US20120237546 Compounds and compositions as tlr activity modulators
09/20/2012US20120237545 Assays for influenza virus hemagglutinins
09/20/2012US20120237544 Bacterial spore having therapeutic agent adsorbed on its surface
09/20/2012US20120237543 Equine rhinitis vaccine
09/20/2012US20120237542 Multivalent pneumococcal polysaccharide-protein conjugate composition
09/20/2012US20120237539 Method for making targeted therapeutic agents directed to soluble targets
09/20/2012US20120237538 RECOMBINANTLY EXPRESSED PLASMODIUM CelTOS ANTIGEN AND METHODS OF USE THEREOF
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis
09/20/2012US20120237536 Combination vaccines against respiratory tract diseases
09/20/2012US20120237535 Therapeutic Compositions For The Treatment of HPV-Induced Diseases
09/20/2012US20120237534 Hyr1 as a target for active and passive immunization against candida
09/20/2012US20120237533 Compositions and Methods for Inducing Apoptosis in Prostate Cancer Cells
09/20/2012US20120237532 Pharmaceutical formulation containing immunoglobulin
09/20/2012US20120237531 Topoisomerase inhibitors
09/20/2012US20120237530 Integrin alpha 8-beta 1-specific monoclonal antibody
09/20/2012US20120237529 Diagnostic antibody assay
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237527 Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
09/20/2012US20120237526 Bace1 inhibitory antibodies
09/20/2012US20120237525 Combination preparation including a cytokine antagonist and corticosteroid
09/20/2012US20120237524 Met inhibitors for enhancing radiotherapy efficacy
09/20/2012US20120237523 Neutralizing antibodies to hiv-1 and their use
09/20/2012US20120237522 Anticancer agent comprising anti-pd-1 antibody or anti-pd-l1 antibody
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237520 Boris isoforms and methods of detecting and treating disease
09/20/2012US20120237519 Pestvirus species
09/20/2012US20120237518 Anti-trop-2 antibody
09/20/2012US20120237517 Antibody Substituting for Function of Blood Coagulation Factor VIII
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237515 Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237513 Vaccines Based on Targeting Antigen to DCIR Expressed on Antigen-Presenting Cells
09/20/2012US20120237512 Activatable Binding Polypeptides and Methods of Identification and Use Thereof
09/20/2012US20120237511 Fgfr1 extracellular domain combination therapies
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
09/20/2012US20120237509 Anti-Mesothelin Antibodies
09/20/2012US20120237508 Fused amino pyridine as hsp90 inhibitors
09/20/2012US20120237507 Monovalent Antigen Binding Proteins
09/20/2012US20120237506 Antigen Binding Proteins
09/20/2012US20120237505 Targeting of cd8+ t-lymphocytes to treat neurodegenerative diseases
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237503 Screening Method and Therapy with Agonists of DDAH I
09/20/2012US20120237502 Method for treating breast cancer and ovarian cancer
09/20/2012US20120237501 Anti-HIV Peptides and Methods of Use Thereof
09/20/2012US20120237500 SCD Fingerprints
09/20/2012US20120237499 Modulators of TDP-43 Mediated Toxicity and Methods of Use Thereof for Identifying Agents Having Efficacy for the Treatment and Prevention of Proteinopathies
09/20/2012US20120237498 4-1bb binding molecules
09/20/2012US20120237478 Modulators of pharmacokinetic properties of therapeutics
09/20/2012US20120237476 Pharmaceutical Compositions for Sustained Release Delivery of Peptides
09/20/2012US20120237475 Novel Inhibitors
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237472 Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012US20120237441 Enhanced b cell cytotoxicity of cdim binding antibody
09/20/2012CA2852056A1 Anti-cd40 antibodies and uses thereof
09/20/2012CA2837348A1 Immunomodulatory agent, combinations, uses thereof and immunotherapy method for recontextualising, reprogramming and restoring immune system in real time
09/20/2012CA2835475A1 Yeast-brachyury immunotherapeutic compositions
09/20/2012CA2830349A1 Re-directed immunotherapy
09/20/2012CA2829968A1 Compositions and methods for the therapy and diagnosis of influenza
09/20/2012CA2829963A1 Human tissue factor antibody and uses thereof
09/20/2012CA2829960A1 Listeria-based adjuvants
09/20/2012CA2829607A1 A method of vaccination comprising a histone deacetylase inhibitor
09/20/2012CA2829226A1 Equine rhinitis vaccine
09/20/2012CA2829096A1 Combination therapies for hematologic malignancies
09/20/2012CA2828688A1 Method for preparing multiple antigen glycopeptide carbohydrate conjugates
09/20/2012CA2828075A1 Use of inhibitors of egfr-family receptors in the treatment of hormone refractory breast cancers
09/20/2012CA2828043A1 Overcoming resistance to erbb pathway inhibitors
09/19/2012EP2500438A2 Novel compositions and methods for the treatment of psoriasis
09/19/2012EP2500419A1 A respiratory syncytial virus with a genomic deficiency complemented in trans
1 ... 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 ... 1823